Menu
Washingtoner
  • Home
  • Business
  • Construction
  • Home
  • Financial
  • Crypto
  • Marketing
  • Fitness
  • Information Technology
Washingtoner

Global Platelet Concentration Systems Market to surpass US$ 1,110.4 million by end of 2027, Says Coherent Market Insights (CMI)
Washingtoner/10099438

Trending...
  • Spokane: SPD Unveils New Public Data Dashboard That Offers Near Real-Time Information with Searchable Parameters
  • Tacoma: Forrest Frank Announces The Jesus Generation Tour
  • Melospeech Inc. Accepts Nomination for HealthTech Startup of the Year
SEATTLE--(BUSINESS WIRE)--According to Coherent Market Insights, the global platelet concentration systems market is estimated to be valued at US$ 286.99 million in 2020 and is expected to exhibit a CAGR of 21.2% during the forecast period (2020-2027).

Key Trends and Analysis:

The global platelet concentration systems market is expected to witness significant growth, owing to increasing launches of Platelet Rich Plasma systems. For instance, in 2014, Mitek Sports Medicine, a leader in orthopedics sports medicine and a part of the DePuy Synthes Companies of Johnson & Johnson, announced launch of PEAK Platelet Rich Plasma (PRP) System, a new device that produces high quality PRP in two and a half minutes.

Launches of PRP products and services is also expected to drive growth of the global platelet concentration systems market. For instance, in October 2013, The Global Stem Cells Group, Inc. announced the launch of Plasma Plus medical services in the Dominican Republic)

Furthermore, increasing geriatric population across the globe has increased the cases of orthopedic conditions and other medical problems that require plasma therapy, which is expected to drive the market growth. According to the United Nations (UN) 2019 report, there were around 703 million people globally aged 65 years and above in 2019, which is expected to reach 1.5 billion by 2050.

Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/4324

Key Market Takeaways:


The global platelet concentration systems market is expected to exhibit a CAGR of 21.2% during the forecast period (2020-2027), as key players are focusing on facility expansion in order to expand their product portfolio. For instance, in October 2017, Arthrex Inc. built a new state-of-the-art surgical device and implant manufacturing facility in Anderson County, South Carolina. This investment is part of Arthrex's global expansion plan to support the development of new and innovative products that help surgeons treat their patients better.

More on Washingtoner
  • America's Bucket Plan Expert Darrin McComas Featured on CNBC
  • Darrin McComas, President of Evergreen Wealth Advisors, Will Be Featured This Weekend on CNBC on "Financial Freedom with Tom Hegna."
  • Crunchbase Ranks Phinge Founder & CEO Robert DeMaio #1 Globally. Meet him in Las Vegas-Week of CES to Learn About Netverse, Patented App-less Platform
  • Tacoma: Dr. Martin Luther King, Jr. Celebration Returns in 2026
  • Spokane: Numerica Skate Ribbon Temporarily Closes Due to Unprecedented Weather

Competitive Landscape:

Key players operating in the global platelet concentration systems market include Anthrax Inc., Stryker Corporation, Johnson & Johnson's, Zimmer Biomet Holdings Inc., Terumo Corporation, Arteriocyte Medical Systems, Inc., Exactech Inc., Harvest Technologies Corp., and Nuo Therapeutics, Inc.

Request Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/4324

Market Segmentation:
  • Global Platelet Concentration Systems Market, By Technology:
    • Apheresis Technology
    • Single Spin Technology
    • Double Spin Technology
  • Global Platelet Concentration Systems Market, By End User:
    • Hospital
    • Orthopedic Clinics
    • Sports Injury Centers
    • Ambulatory Surgical Centers
  • Global Platelet Concentration Systems Market, By Region:
    • North America
      • By Country:
        • U.S.
        • Canada
    • Europe
      • By Country:
        • U.K.
        • Germany
        • France
        • Spain
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Country:
        • China
        • India
        • Japan
        • Australia
        • ASEAN
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Middle East
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa

Related Market Intelligence Reports:

More on Washingtoner
  • IODefi Introduces New Web3 Infrastructure Framework as XRP Ledger Development Gains Global Attention
  • Terizza Forms Strategic Collaboration with UC San Diego to Pioneer Next-Generation Distributed AI Infrastructure
  • Tacoma: Hams for the Holidays – Ham Giveaway for Those in Need
  • Spokane: Water Rescue Team Deployed to Western Washington Flood Emergency
  • EnergyStrat Launches Global LNG Risk Outlook 2025–2030

Plasma Therapy Market, By Type (Pure PRP, Leucocyte-rich PRP, Pure Platelet-rich Fibrin (PRF), and Leukocyte-rich Fibrin (L-PRF)), By Application (Infections Diseases, Dental, Nerve Injury, Cardiac Muscle Injury, and Other Applications), By End-User (Hospitals & Clinics, Research Institutes, and Others) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 – 2027

Read more: https://www.coherentmarketinsights.com/market-insight/plasma-therapy-market-4155

Europe Platelet rich Plasma Market, By Product Type (Instruments, Kits (Kit By Type (Pure Platelet-Rich Plasma (P-PRP), Leukocyte-Rich Platelet-Rich Plasma (L-PRP), Leukocyte-Platelet-Rich Fibrin (L-PRF), Pure Platelet-Rich Fibrin (P-PRF)),Kit By Origin (Autologous Platelet-Rich Plasma, Homologus Platelet-Rich Plasma, Allogeneic Platelet-Rich Plasma))), By Application (Knee, Elbow, Foot and Ankle, Shoulder, CMF, Others) - Size, Share, Outlook, and Opportunity Analysis, 2019 – 2027

Read more: https://www.coherentmarketinsights.com/market-insight/europe-platelet-rich-plasma-market-3346

About Us:

Coherent Market Insights
is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide.
Show All News | Report Violation

0 Comments
1000 characters max.

Latest on Washingtoner
  • Accelerating Precious Metals Expansion and Digital Asset Innovation Ahead of 2026: Asia Broadband Inc. (Stock Symbol: AABB)
  • Tacoma City Council Passes Ordinance 29086 Amending the Rental Housing Code and Landlord Fairness Code Initiative
  • City of Tacoma Advances Vision Zero Goals with Updated Traffic Safety Program
  • Tacoma: Transportation Impact Fees to Help Fund Critical Infrastructure and Enhance Safety
  • Tacoma: A Statement from Mayor Victoria Woodards, At-Large Council Member Olgy Diaz, and District 4 Council Member Sandesh Sadalge on Resolution 41817
  • City of Tacoma Deepens Cultural Ties with Croatia, Designates Split as New Sister City
  • Tacoma City Council Designates Kochi, India as New Friendship City
  • Spokane: Welding Sparks Ignite Multi-Business Fire on Holyoke Avenue
  • City Council Member Michael Cathcart Selected As Chair of Spokane Regional Health District Board of Health
  • Naturism Resurgence (NRE) Announces the World's First Standardised Stigma Measure (SSM) for Naturism
  • London Art Exchange Emerges as a Leading Force in UK Contemporary Art, Elevating Three Artists to Secondary-Market Success
  • City of Spokane and City Council Announce 2026 Legislative Agenda
  • myLAB Box Expands, Becoming the First and Only At-Home Testing Company to Serve the Entire Family—Human and Furry—with New Pet Intolerance Test
  • Entering 2026 with Expanding Footprint, Strong Industry Tailwinds, and Anticipated Q3 Results: Off The Hook YS Inc. (N Y S E American: OTH)
  • Tiger-Rock Martial Arts Appoints Jami Bond as Vice President of Growth
  • Super League (N A S D A Q: SLE) Enters Breakout Phase: New Partnerships, Zero Debt & $20 Million Growth Capital Position Company for 2026 Acceleration
  • Finland's Gambling Reform Promises "Single-Click" Block for All Licensed Sites
  • Private Keys Are a Single Point of Failure: Security Advisor Gideon Cohen Warns MPC Technology Is Now the Only Defense for Institutional Custody
  • Compliance Is the Ticket to Entry: Legal Advisor Gabriela Moraes Analyzes RWA Securitization Paths Under Brazil's New Legislation
  • Visit Tri-Cities, Washington Names Vijay Patel as Tourism Champion of the Year
_catLbl0 _catLbl1

Popular on Washingtoner

  • Liquidity Aggregation: US-Registered JHKXWL Integrates AI Analytics for Brazilian and Global Institutional Traders - 1106
  • BumblebeeSmart Introduces Rounded Busy Board Set for Preschoolers
  • Liftoff Enterprises Launches Liftoff Spotlight,™ A Nationally Broadcast Platform Turning Conversations Into Revenue
  • Cut Costs & Boost Profits with the First Major Upgrade in 30 YEARS Replacing Rotary Lasers and Historic Clear Tube Altimeter Bubbles
  • Turbo vs. Experts: Tracking OddsTrader's AI Performance at the NFL's Midpoint
  • Outreaching.io Appoints Rameez Ghayas Usmani as CEO, Recognized as Best HARO Link Building Expert in the United States
  • City of Spokane Funds 50 New Shelter Beds, Mobile Medication Assisted Treatment Services
  • UV Weathering Test Chamber vs Xenon Arc Test Chamber: What's the Right Solution for Your Products
  • Dispelling Holiday Suicide Myth: CDC Data Shows Suicide Rates Lowest in December; International Survivors of Suicide Day Emphasizes Need for Action
  • Revenue Expansion, Regulatory Momentum, and a Leadership Position in the $750 Million Suicidal Depression: NRx Pharmaceuticals (N A S D A Q: NRXP)

Similar on Washingtoner

  • Contracting Resources Group Receives 2025 HIRE Vets Platinum Medallion Award from the U.S. Department of Labor
  • EnergyStrat Launches Global LNG Risk Outlook 2025–2030
  • Strong Revenue Gains, Accelerating Growth, Strategic Hospital Expansion & Uplisting Advancements: Cardiff Lexington Corporation (Stock Symbol: CDIX)
  • Rigani Press Announces Breakthrough Book for Health IT and Medical Leaders to Forge the Road to Responsible AI
  • FreeTo.Chat - The bold, Anonymous Confession Platform, ushers in a new era of tension relief
  • "I Make Music Not Excuses" Journal by Anthony Clint Jr. Becomes International Amazon Best Seller, Empowering Music Creators Worldwide
  • Accelerating Precious Metals Expansion and Digital Asset Innovation Ahead of 2026: Asia Broadband Inc. (Stock Symbol: AABB)
  • Naturism Resurgence (NRE) Announces the World's First Standardised Stigma Measure (SSM) for Naturism
  • London Art Exchange Emerges as a Leading Force in UK Contemporary Art, Elevating Three Artists to Secondary-Market Success
  • Entering 2026 with Expanding Footprint, Strong Industry Tailwinds, and Anticipated Q3 Results: Off The Hook YS Inc. (N Y S E American: OTH)
Copyright © 2025 washingtoner.com | Terms of Service | Privacy Policy | Contact Us | Contribute